Piramal Pharma shareholding pattern

PPLPHARMA

HealthcareLarge

192.75

0.70 (0.36%)
Last updated on 22 Aug, 2025 | 15:58 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Piramal Pharma Shareholding Pattern

  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

34.86%

Mutual Fund

12.32%

Insurance

1.67%

Foreign Institutional Investors

30.86%

Domestic Institutional Investors

0.26%

Retail

20.03%

Others

0%

Total Promoters
MAR '25
34.95%
JUN '25
34.86%

Piramal Pharma FAQs

As of 08-2025, the promoter shareholding in Piramal Pharma stands at 34.86% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Piramal Pharma is 30.86% and 0.26% respectively.

The retail shareholding of the Piramal Pharma is 20.03%.

Changes in shareholding patterns of Piramal Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Piramal Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.